Replies to post #250017 on Biotech Values

[Mufaso]

Will do. I will also add Shionogi's S-309309 which has is an MGAT2 inhibitor. It completed ph1 (not much detail available on results there that I can find). There is some detail Shionogi's investor section saying it had promising safety but no info on % of weight loss etc. It is in ph2

https://clinicaltrials.gov/study/NCT05925114?term=%20S-309309&rank=2

Been doing some research to see if I missed anything else of significance and will update when I have run a few more things down.